271 related articles for article (PubMed ID: 23613951)
1. Sexually dimorphic effects of catechol-O-methyltransferase (COMT) inhibition on dopamine metabolism in multiple brain regions.
Laatikainen LM; Sharp T; Harrison PJ; Tunbridge EM
PLoS One; 2013; 8(4):e61839. PubMed ID: 23613951
[TBL] [Abstract][Full Text] [Related]
2. Modulation of hippocampal dopamine metabolism and hippocampal-dependent cognitive function by catechol-O-methyltransferase inhibition.
Laatikainen LM; Sharp T; Bannerman DM; Harrison PJ; Tunbridge EM
J Psychopharmacol; 2012 Dec; 26(12):1561-8. PubMed ID: 22815336
[TBL] [Abstract][Full Text] [Related]
3. Effect of intracerebral 6-nitronoradrenaline, an endogenous catechol-O-methyltransferase (COMT) inhibitor, on striatal dopamine metabolism in anaesthetised rats.
Huotari M; Passlin M; Nordberg HL; Forsberg M; Kotisaari S; Tuomisto L; Shintani F; Tanaka KF; Reenilä I; Laitinen K; Männistö PT
J Neurosci Methods; 2001 Aug; 109(1):47-52. PubMed ID: 11489299
[TBL] [Abstract][Full Text] [Related]
4. Novel, non-nitrocatechol catechol-O-methyltransferase inhibitors modulate dopamine neurotransmission in the frontal cortex and improve cognitive flexibility.
Byers S; Buchler IP; DePasquale M; Rowley HL; Kulkarni RS; Pinder L; Kolobova A; Li C; Au V; Akuma D; Zhang G; Wei H; Cheetham SC; Barrow JC; Carr GV
Psychopharmacology (Berl); 2020 Sep; 237(9):2695-2707. PubMed ID: 32474681
[TBL] [Abstract][Full Text] [Related]
5. Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex.
Tunbridge EM; Bannerman DM; Sharp T; Harrison PJ
J Neurosci; 2004 Jun; 24(23):5331-5. PubMed ID: 15190105
[TBL] [Abstract][Full Text] [Related]
6. Effects of peripheral and central catechol-O-methyltransferase inhibition on striatal extracellular levels of dopamine: a microdialysis study in freely moving rats.
Napolitano A; Bellini G; Borroni E; Zürcher G; Bonuccelli U
Parkinsonism Relat Disord; 2003 Jan; 9(3):145-50. PubMed ID: 12573869
[TBL] [Abstract][Full Text] [Related]
7. No change of brain extracellular catecholamine levels after acute catechol-O-methyltransferase inhibition: a microdialysis study in anaesthetized rats.
Li YH; Wirth T; Huotari M; Laitinen K; MacDonald E; Männistö PT
Eur J Pharmacol; 1998 Sep; 356(2-3):127-37. PubMed ID: 9774242
[TBL] [Abstract][Full Text] [Related]
8. Membrane bound catechol-O-methytransferase is the dominant isoform for dopamine metabolism in PC12 cells and rat brain.
Su Y; DePasquale M; Liao G; Buchler I; Zhang G; Byers S; Carr GV; Barrow J; Wei H
Eur J Pharmacol; 2021 Apr; 896():173909. PubMed ID: 33503461
[TBL] [Abstract][Full Text] [Related]
9. Catechol-O-methyltransferase inhibition increases striatal L-dopa and dopamine: an in vivo study in rats.
Brannan T; Martínez-Tica J; Yahr MD
Neurology; 1992 Mar; 42(3 Pt 1):683-5. PubMed ID: 1549240
[TBL] [Abstract][Full Text] [Related]
10. Tolcapone enhances food-evoked dopamine efflux and executive memory processes mediated by the rat prefrontal cortex.
Lapish CC; Ahn S; Evangelista LM; So K; Seamans JK; Phillips AG
Psychopharmacology (Berl); 2009 Jan; 202(1-3):521-30. PubMed ID: 18854987
[TBL] [Abstract][Full Text] [Related]
11. Brain catechol-O-methyltransferase (COMT) inhibition by tolcapone counteracts recognition memory deficits in normal and chronic phencyclidine-treated rats and in COMT-Val transgenic mice.
Detrait ER; Carr GV; Weinberger DR; Lamberty Y
Behav Pharmacol; 2016 Aug; 27(5):415-21. PubMed ID: 26919286
[TBL] [Abstract][Full Text] [Related]
12. Characterization of non-nitrocatechol pan and isoform specific catechol-O-methyltransferase inhibitors and substrates.
Robinson RG; Smith SM; Wolkenberg SE; Kandebo M; Yao L; Gibson CR; Harrison ST; Polsky-Fisher S; Barrow JC; Manley PJ; Mulhearn JJ; Nanda KK; Schubert JW; Trotter BW; Zhao Z; Sanders JM; Smith RF; McLoughlin D; Sharma S; Hall DL; Walker TL; Kershner JL; Bhandari N; Hutson PH; Sachs NA
ACS Chem Neurosci; 2012 Feb; 3(2):129-40. PubMed ID: 22860182
[TBL] [Abstract][Full Text] [Related]
13. Genotype-Dependent Effects of COMT Inhibition on Cognitive Function in a Highly Specific, Novel Mouse Model of Altered COMT Activity.
Barkus C; Korn C; Stumpenhorst K; Laatikainen LM; Ballard D; Lee S; Sharp T; Harrison PJ; Bannerman DM; Weinberger DR; Chen J; Tunbridge EM
Neuropsychopharmacology; 2016 Dec; 41(13):3060-3069. PubMed ID: 27388330
[TBL] [Abstract][Full Text] [Related]
14. Modulation of rat brain endogenous dopamine metabolism by new inhibitors of catechol O-methyltransferase.
Törnwall M; Tuomainen P; Männistö PT
Eur J Pharmacol; 1993 Aug; 239(1-3):39-45. PubMed ID: 8223912
[TBL] [Abstract][Full Text] [Related]
15. [Microdialysis study of tolcapone effect during blockage of neuronal dopamine reuptake caused by GBR-12909].
Budygin EA; Gaĭnetdinov RR; Raevskiĭ KS; Li IH; Mannisto PT
Eksp Klin Farmakol; 1997; 60(5):8-10. PubMed ID: 9483396
[TBL] [Abstract][Full Text] [Related]
16. Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism.
Giakoumaki SG; Roussos P; Bitsios P
Neuropsychopharmacology; 2008 Dec; 33(13):3058-68. PubMed ID: 18536698
[TBL] [Abstract][Full Text] [Related]
17. Elimination of extracellular dopamine in the medial prefrontal cortex of conscious mice analysed using selective enzyme and uptake inhibitors.
Tammimaki A; Aonurm-Helm A; Kaenmaki M; Mannisto PT
J Physiol Pharmacol; 2016 Apr; 67(2):301-9. PubMed ID: 27226189
[TBL] [Abstract][Full Text] [Related]
18. Differential COMT expression and behavioral effects of COMT inhibition in male and female Wistar and alcohol preferring rats.
McCane AM; DeLory MJ; Timm MM; Janetsian-Fritz SS; Lapish CC; Czachowski CL
Alcohol; 2018 Mar; 67():15-22. PubMed ID: 29310047
[TBL] [Abstract][Full Text] [Related]
19. Effects of tolcapone, a novel catechol-O-methyltransferase inhibitor, on striatal metabolism of L-dopa and dopamine in rats.
Napolitano A; Zürcher G; Da Prada M
Eur J Pharmacol; 1995 Feb; 273(3):215-21. PubMed ID: 7737328
[TBL] [Abstract][Full Text] [Related]
20. Microdialysis studies on the action of tolcapone on pharmacologically-elevated extracellular dopamine levels in conscious rats.
Huotari M; Gainetdinov R; Männistö PT
Pharmacol Toxicol; 1999 Nov; 85(5):233-8. PubMed ID: 10608486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
